AAMC ERAS Antitrust Lawsuit, Were You Affected? — Buhrke v. Association of American Medical Colleges

If you paid ERAS application fees to apply for a medical residency or fellowship, a Phoenix surgeon says you were overcharged — and she’s suing to prove it. Kaitlin Buhrke, DO, filed a proposed antitrust class action against the Association of American Medical Colleges in Washington, D.C. federal court, claiming AAMC’s residency application platform is a monopoly. Here’s what that means if you’ve ever used ERAS.

AAMC ERAS Lawsuit — Key Facts

Lawsuit Filed	August 18, 2026
Defendant	Association of American Medical Colleges (AAMC)
Named Plaintiff	Kaitlin Buhrke, DO — general surgeon, Phoenix, Arizona
Alleged Harm	Supracompetitive fees for medical residency and fellowship applications via ERAS
Law Alleged	Federal antitrust law — specific statutory counts UNVERIFIED, full complaint text not accessible through public non-paywalled sources
Who Is Affected	Medical school graduates and physicians who paid ERAS application fees
Court & Case Number	U.S. District Court for the District of Columbia; case number UNVERIFIED — not confirmed through publicly accessible court records
Current Stage	Complaint filed; no rulings issued yet
Lead Plaintiff Deadline	N/A — this is not a securities class action
Settlement Status	Active litigation. No settlement, no payout, no claim form exists
Last Updated	September 3, 2026

Who Is AAMC and Why Is It Being Sued Over ERAS Fees?

AAMC is the Washington, D.C. nonprofit that runs the Electronic Residency Application Service, the platform nearly every U.S. medical graduate must use to apply for residency and fellowship positions. Buhrke’s complaint alleges AAMC controls this market with little real competition, which lets it set fees well above what a competitive market would allow. The complaint claims AAMC uses the resulting revenue to enrich its executives while member medical schools benefit from the arrangement.

What Does the Lawsuit Claim AAMC Did?

Buhrke’s complaint alleges AAMC illegally monopolizes the market for medical residency and fellowship application platforms. Doctors have no real alternative to ERAS if they want a U.S. residency spot, and the complaint says AAMC leveraged that position to charge fees far above competitive levels.

The complaint states plainly that AAMC “has violated federal antitrust law to gouge residency and fellowship applicants attempting to follow their dreams, [make] better lives for themselves and their families, and make a difference for patients and their communities.” That’s a striking line for a filing against a nonprofit medical education association — most applicants assume a nonprofit means low fees, not a subject of monopoly allegations.

Here’s something not every outlet covering this case has flagged: the same week Buhrke’s suit hit AAMC, a nearly identical complaint was filed against the organization that runs law school admissions, alleging the same kind of fee-gouging through its own application platform. Two separate application gatekeepers, two nearly simultaneous antitrust suits — plaintiffs’ counsel appear to be testing this theory across professional school admissions broadly, not just medicine.

Every med school graduate who’s used ERAS has felt this same friction: pay the platform’s fee or don’t apply at all. That’s exactly the lack of choice antitrust law is meant to police.

Are You Part of the AAMC ERAS Lawsuit?

This is a proposed class action — no court has certified a class yet, and there’s no settlement or claim form. Here’s how to know if the allegations could eventually affect you:

• Medical school graduates who paid ERAS fees to apply for residency programs
• Physicians who paid ERAS fees to apply for fellowship programs
• Applicants who used the platform in any recent application cycle, since the exact class period hasn’t been defined in public reporting

AAMC ERAS Applicants Outside Washington, D.C. — Are You Still Covered?

Yes. This is a federal antitrust case, not a state claim, so it isn’t limited to D.C. residents. ERAS is used by residency and fellowship applicants nationwide, and the proposed class would cover affected applicants regardless of which state they applied from or matched in.

If AAMC’s fee structure affected you once, it likely affected you every year you used the platform — residency and fellowship applicants often pay these fees multiple times across a single application cycle.

Not sure if you qualify for the AAMC ERAS antitrust lawsuit? A free consultation with an antitrust attorney can help you understand your options while this case is still active.

What Are Buhrke and Other ERAS Applicants Asking the Court to Award?

There’s no money on the table yet. No settlement exists, and no claim form exists. Anyone telling you otherwise about this case isn’t working from verified information.

What Could AAMC ERAS Applicants Receive If This Settles?

It’s impossible to predict a number this early. Outcomes in antitrust cases like this depend on class certification, the strength of the monopoly evidence, and eventual settlement negotiations — if the case gets that far at all. Many proposed antitrust class actions are narrowed, dismissed in part, or settled for amounts that only become clear once a court reviews the evidence.

That uncertainty is normal at this stage. Cases like the decades-old Jung v. AAMC antitrust suit over the residency Match process show these disputes can run for years before any resolution — and that one ended in a legislative exemption rather than a court judgment.

What Should ERAS Applicants Do Right Now?

1. You don’t need to do anything to preserve your rights at this stage — no claim form exists yet, and nothing has been certified
2. Save your ERAS payment records: receipts, credit card statements, or account history showing what you paid and when
3. Note which application cycle or cycles you used ERAS in, since the eventual class period will likely hinge on these dates
4. Watch for class certification news — that’s the next major milestone in a case like this
5. Monitor the docket in the U.S. District Court for the District of Columbia for developments
6. If you paid significant ERAS fees across multiple cycles, consider a free consultation with an antitrust attorney now rather than waiting for a certification decision

Nobody needs to file anything today. But applicants who kept clean payment records will be in a much stronger position if this case eventually reaches a claims process.

AAMC ERAS Lawsuit — Full Timeline

Milestone	Date
Complaint filed against AAMC	August 18, 2026
Companion complaint filed against law school admissions platform operator	August 18, 2026
Class certification decision	UNVERIFIED — not yet scheduled in public reporting
Next scheduled hearing	UNVERIFIED — not yet available in public reporting
Expected resolution	UNVERIFIED — too early in the case to estimate

AAMC ERAS Antitrust Lawsuit — Frequently Asked Questions

Is there a class action lawsuit against AAMC over ERAS fees right now? 

Yes. Kaitlin Buhrke, DO, filed a proposed antitrust class action against AAMC in the U.S. District Court for the District of Columbia on August 18, 2026, alleging AAMC monopolizes residency and fellowship application platforms.

Do I need to do anything right now to be part of the AAMC lawsuit?

 No. This case hasn’t reached class certification, and there’s no claim form. If you paid ERAS fees, save your payment records in case that changes.

When will the AAMC ERAS case settle?

 There’s no timeline. The case was just filed in August 2026 and hasn’t reached class certification, let alone settlement talks.

Can I file my own lawsuit against AAMC instead of joining the class?

 Individual antitrust claims are legally possible, but they’re expensive to litigate alone given the resources a defendant like AAMC can bring to a case. An antitrust attorney can walk you through whether an individual claim makes sense for your situation.

How will I find out if the AAMC ERAS lawsuit settles? 

Watch the docket in the U.S. District Court for the District of Columbia, or check back here — this page will be updated if the case reaches a settlement or certification milestone.

What does “lead plaintiff” mean for the AAMC case?

 This isn’t a securities case, so there’s no lead plaintiff deadline in the way investors see in stock-drop suits. Buhrke is currently the sole named plaintiff representing the proposed class.

What specific laws does AAMC allegedly violate? 

The complaint alleges violations of federal antitrust law tied to monopolization of the residency and fellowship application market. The specific statutory sections cited in the complaint are UNVERIFIED pending access to the full filing.

How much could ERAS applicants get if this case eventually settles? 

There’s no way to estimate this. No settlement fund exists, and any future number would depend on class size, certification outcome, and negotiated terms — treat any specific dollar figure you see elsewhere as unconfirmed.

Sources Used in This AAMC ERAS Antitrust Article

• Law360 — “AAMC Gouges Med Residency Applicants, Antitrust Suit Says,” Aug. 18, 2026: https://www.law360.com/healthcare-authority/other/articles/2515081
• Bloomberg Law — “Medical College Association Accused of Application Price-Fixing”: https://news.bloomberglaw.com/antitrust/medical-college-association-accused-of-application-price-fixing
• RamaOnHealthcare — “Doctor Sues Over Residency Application System”: https://ramaonhealthcare.com/doctor-sues-over-residency-application-system/

Researched and written by Israr Ahmad, legal content researcher and founder of AllAboutLawyer.com. Facts verified against Law360 and Bloomberg Law reporting on the complaint as of September 3, 2026. Case number and specific statutory counts remain unverified pending access to the full court filing. Last Updated: September 3, 2026.

This article is for informational purposes only and does not constitute legal advice. Laws vary by state and individual circumstances differ. For advice about your specific situation, consult a qualified attorney.